PubMed:28777492 / 0-114 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":114},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":114},"obj":"Sentence"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":114},"obj":"Sentence"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-entities","denotations":[{"id":"13250","span":{"begin":0,"end":8},"obj":"GeneOrGeneProduct"},{"id":"13251","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"},{"id":"13252","span":{"begin":37,"end":43},"obj":"DiseaseOrPhenotypicFeature"},{"id":"13253","span":{"begin":65,"end":74},"obj":"ChemicalEntity"},{"id":"13254","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"13250","obj":"NCBIGene:53380"},{"id":"A2","pred":"db_id","subj":"13251","obj":"NCBIGene:20848"},{"id":"A3","pred":"db_id","subj":"13252","obj":"MESH:D009369"},{"id":"A4","pred":"db_id","subj":"13253","obj":"MESH:D000077157"},{"id":"A5","pred":"db_id","subj":"13254","obj":"MESH:D006528"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":104,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0007256"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0004993"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":9,"end":16},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":23,"end":33},"obj":"GeneOrGeneProduct"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":37,"end":43},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"DISEASE"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D006528"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0007256"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":37,"end":43},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"DISEASE"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D006528"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":37,"end":43},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"DISEASE"},{"id":"A2","pred":"#label","subj":"T2","obj":"D006528"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":65,"end":74},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077157"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T1","span":{"begin":65,"end":74},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":17,"end":22},"obj":"GeneOrGeneProduct"},{"id":"T74841","span":{"begin":0,"end":8},"obj":"GeneOrGeneProduct"},{"id":"T69082","span":{"begin":89,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T24854","span":{"begin":37,"end":43},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077157"},{"id":"A58937","pred":"#label","subj":"T69082","obj":"D006528"},{"id":"A35740","pred":"#label","subj":"T24854","obj":"DISEASE"}],"text":"Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma."}